Effects of buyang huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Zhou, Ying Chun ^a   Liu, Bin ^a   Li, Ying Jia ^a   Jing, Lin Lin ^a   Wen, Ge ^a   Tang, Jing ^a   Xu, Xin ^b   Lv, Zhi Ping ^a   Sun, Xue Gang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b YUEBEI PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BUYANG HUANWU DECOCTION; CASPASE 3; CHINESE DRUG; COLLAGEN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA 6; PEROXIREDOXIN 6; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; HEART WEIGHT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

EID: 84867775158     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/385247     Document Type: Article

References (45)

1. Lloyd-Jones D., Adams R. J., Brown T. M., Carnethon M., Dai S., De Simone G., Ferguson T. B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., Haase N., Hailpern S., Ho P. M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M. M., Meigs J., Mozaffarian D., Mussolino M., Nichol G., Roger V. L., Rosamond W., Sacco R., Sorlie P., Stafford R., Thom T., Wasserthiel-Smoller S., Wong N. D., Wylie-Rosett J., Heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2010 121 7 e46 e215 2-s2.0-77649126524 10.1161/CIRCULATIONAHA.109. 192667
2. Udelson J. E., Konstam M. A., Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction. Journal of Cardiac Failure 2002 8 6, supplement S465 S471 2-s2.0-0036956733 10.1054/jcaf.2002.129289 (Pubitemid 36083098)
3. Udelson J. E., Patten R. D., Konstam M. A., New concepts in post-infarction vetricular remodeling. Reviews in Cardiovascular Medicine 2003 4 supplement 3 S3 S12 2-s2.0-0141505923 (Pubitemid 37220650)
4. Zeng X., He H., Yang J., Yang X., Wu L., Yu J., Li L., Temporal effect of Guanxin No. 2 on cardiac function, blood viscosity and angiogenesis in rats after long-term occlusion of the left anterior descending coronary artery. Journal of Ethnopharmacology 2008 118 3 485 494 2-s2.0-47749096294 10.1016/j.jep.2008.05.017
5. Bu P. L., Zhao X. Q., Wang L. L., Zhao Y. X., Li C. B., Zhang Y., Tong-xin-luo capsule inhibits left venticular remodeling in spontaneously hypertensive rats by enhancing PPAR- γ expression and suppressing NF- κ B activity. Chinese Medical Journal 2008 121 2 147 154 2-s2.0-39049153969 (Pubitemid 351247889)
6. Cai G., Liu B., Liu W., Tan X., Rong J., Chen X., Tong L., Shen J., Buyang Huanwu Decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains. Journal of Ethnopharmacology 2007 113 2 292 299 2-s2.0-34547821365 10.1016/j.jep.2007.06. 007 (Pubitemid 47239253)
7. Wang L., Jiang D. M., Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia/reperfusion injury in rats. Journal of Ethnopharmacology 2009 124 2 219 223 2-s2.0-67449132104 10.1016/j.jep.2009.04.045
8. Li X. M., Bai X. C., Qin L. N., Huang H., Xiao Z. J., Gao T. M., Neuroprotective effects of Buyang Huanwu Decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats. Neuroscience Letters 2003 346 1-2 29 32 2-s2.0-0038383786 10.1016/S0304-3940(03)00522-6 (Pubitemid 36792186)
9. Zhang H., Wang W. R., Lin R., Zhang J. Y., Ji Q. L., Lin Q. Q., Yang L. N., Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats. Journal of Ethnopharmacology 2010 130 1 98 102 2-s2.0-77953808121 10.1016/j.jep.2010.04. 017
10. Yang G., Fang Z., Liu Y., Zhang H., Shi X., Ji Q., Lin Q., Lin R., Protective effects of Chinese traditional medicine Buyang Huanwu Decoction on myocardial injury. Evidence-Based Complementary and Alternative Medicine 2011 2011 7 930324 10.1093/ecam/nep013
11. Xu D., Zhang F., Clinical study on inproving effect with Buyang Huanwu decoction (BYHWD) on cardiac remodeling and heart function in patients after myocardial infarction. Integrated Traditional Chinese and Western Medicine In Practice of Critical Care Medicine 2001 8 298 300
12. Zheng Q., Zhou Y., Effect of Buyang Huanwu Decoction on improving left ventricular function in rats with ventricular remodeling after myocardial infarction. Journal of New Chinese Medicine 2010 42 109 111
13. Jia H., Zhang Y., Li L., Dingxin recipe prevents ischemia/reperfusion- induced arrhythmias via up-regulating prohibitin and suppressing inflammatory responses. Chinese Journal of Integrative Medicine 2012 18 2 120 129
14. Boissiere J., Eder V., Machet M. C., Courteix D., Bonnet P., Moderate exercise training does not worsen left ventricle remodeling and function in untreated severe hypertensive rats. Journal of Applied Physiology 2008 104 2 321 327 2-s2.0-38949209855 10.1152/japplphysiol.00442.2007 (Pubitemid 351231478)
15. Sun X. G., Zhong X. L., Liu Z. F., Cai H. B., Fan Q., Wang Q. R., Liu Q., Song Y. H., He S. Q., Zhang X. F., Lu Z. P., Proteomic analysis of chronic restraint stress-induced Gan-stagnancy syndrome in rats. Chinese Journal of Integrative Medicine 2010 16 6 510 517 2-s2.0-79952555666 10.1007/s11655-010- 0525-z
16. Cai H. B., Sun X. G., Liu Z. F., Liu Y. W., Tang J., Liu Q., Ji B. M., Song Y. H., Zhou Y. C., Yang M. H., Lv Z. P., Effects of dahuangzhechong pills on cytokines and mitogen activated protein kinase activation in rats with hepatic fibrosis. Journal of Ethnopharmacology 2010 132 1 157 164 2-s2.0-77957791564 10.1016/j.jep.2010.08.019
17. Wang Q. R., Yao X. Q., Wen G., Fan Q., Li Y. J., Fu X. Q., Li C. K., Sun X. G., Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression. Oncology Letters 2011 2 1 43 47 2-s2.0-78751504804 10.3892/ol.2010.215
18. Jain M., Liao R., Ngoy S., Whittaker P., Apstein C. S., Eberli F. R., Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats. Cardiovascular Research 2000 46 1 66 72 2-s2.0-0034060165 10.1016/S0008-6363(99)00429-0 (Pubitemid 30155946)
19. John S. W. M., Krege J. H., Oliver P. M., Hagaman J. R., Hodgin J. B., Pang S. C., Flynn T. G., Smithies O., Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995 267 5198 679 681 2-s2.0-0028943463
20. Steinhelper M. E., Cochrane K. L., Field L. J., Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 1990 16 3 301 307 2-s2.0-0024997561 (Pubitemid 20313292)
21. Burnett J. C., Kao P. C., Hu D. C., Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986 231 4742 1145 1147 2-s2.0-0022471069 (Pubitemid 16016312)
22. Nishikimi T., Maeda N., Matsuoka H., The role of natriuretic peptides in cardioprotection. Cardiovascular Research 2006 69 2 318 328 2-s2.0-30744450770 10.1016/j.cardiores.2005.10.001 (Pubitemid 43098788)
23. Qian J., Ren X., Wang X., Zhang P., Jones W. K., Molkentin J. D., Fan G. C., Kranias E. G., Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death. Circulation Research 2009 105 12 1223 1231 2-s2.0-73349134699 10.1161/CIRCRESAHA.109.200378
24. Nicolaou P., Knöll R., Haghighi K., Fan G. C., Dorn G. W., Hasenfu G., Kranias E. G., Human mutation in the anti-apoptotic heat shock protein 20 abrogates its cardioprotective effects. The Journal of Biological Chemistry 2008 283 48 33465 33471 2-s2.0-57749119543 10.1074/jbc.M802307200
25. Nagy N., Malik G., Fisher A. B., Das D. K., Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. American Journal of Physiology 2006 291 6 H2636 H2640 2-s2.0-33845426445 10.1152/ajpheart.00399.2006 (Pubitemid 44904061)
26. Sun X. G., Fu X. Q., Cai H. B., Liu Q., Li C. H., Liu Y. W., Li Y. J., Liu Z. F., Song Y. H., Lv Z. P., Proteomic analysis of protective effects of polysaccharides from Salvia miltiorrhiza against immunological liver injury in mice. Phytotherapy Research 2011 25 1087 1094 2-s2.0-79953752273 10.1002/ptr.3487
27. Wu C. F., Bishopric N. H., Pratt R. E., Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. The Journal of Biological Chemistry 1997 272 23 14860 14866 2-s2.0-0030954131 10.1074/jbc.272.23.14860 (Pubitemid 27251756)
28. Ma L., Guan Z. Z., Effect of astragalus injection on left ventricular remodeling and apoptotic gene caspase-3 in rats after myocardial infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005 25 7 646 649 2-s2.0-32944469999
29. Zhao Z., Wang W., Wang F., Effects of astragaloside IV on heart failure in rats. Chinese Medicine 2009 4, article 6 10.1186/1749-8546-4-6
30. Shen X., Mo X. Y., Du X. Y., The protective effect of total paeony glycoside on apoptosis in myocardial ischemic rats. Chinese Pharmacological Bulletin 2007 23 10 1300 1305 2-s2.0-37049034444
31. Shangguan H. J., Xu J., Guan H. S., Zhao Y. F., Effects of radix angelicae sinensis on myocardial apoptosis and ventricular remolding after myocardial infarction. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2008 15 39 45
32. Lin Y. L., Wang G. J., Huang C. L., Lee Y. C., Liao W. C., Lai W. L., Lin Y. J., Huang N. K., Ligusticum chuanxiong as a potential neuroprotectant for preventing serum deprivation-induced apoptosis in rat pheochromocytoma cells: functional roles of mitogen-activated protein kinases. Journal of Ethnopharmacology 2009 122 3 417 423 2-s2.0-63949085239 10.1016/j.jep.2009.02. 011
33. Li Y. D., Ma Y. H., Zhao J. X., Zhao X. K., Protection of ultra-filtration extract from Danggui Buxue Decoction on oxidative damage in cardiomyocytes of neonatal rats and its mechanism. Chinese Journal of Integrative Medicine 2011 17 854 859
34. Liu L., Duan J. A., Tang Y., Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. Journal of Ethnopharmacology 2012 139 381 387
35. Kasim M., Kiat A. A., Rohman M. S., Hanifah Y., Kiat H., Improved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot study. Journal of Alternative and Complementary Medicine 2009 15 5 539 544 2-s2.0-67149144584 10.1089/acm.2008.0506
36. Hwang C. M., Kim D. I., Huh S. H., In vivo evaluation of lumbrokinase, a fibrinolytic enzyme extracted from Lumbricus rubellus, in a prosthetic vascular graft. Journal of Cardiovascular Surgery 2002 43 6 891 894 2-s2.0-0036920085
37. Fan G. C., Ren X., Qian J., Yuan Q., Nicolaou P., Wang Y., Jones W. K., Chu G., Kranias E. G., Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury. Circulation 2005 111 14 1792 1799 2-s2.0-17144393307 10.1161/01.CIR.0000160851.41872.C6 (Pubitemid 40525144)
38. Hoehhauser E., Kivity S., Offen D., Maulik N., Otani H., Barhum Y., Pannet H., Shneyvays V., Shainberg A., Goldshtaub V., Tobar A., Vidne B. A., Bax ablation protects against myocardial ischemiareperfusion injury in transgenic mice. American Journal of Physiology 2003 284 6 H2351 H2359 2-s2.0-17344375146 (Pubitemid 36622451)
39. Zhao W., Fan G. C., Zhang Z. G., Bandyopadhyay A., Zhou X., Kranias E. G., Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis. Basic Research in Cardiology 2009 104 4 377 389 2-s2.0-67349283991 10.1007/s00395-008-0764-6
40. Fisher A. B., Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase a2 activities. Antioxidants & Redox Signaling 2011 15 3 831 844 2-s2.0-79953249112 10.1089/ars.2010.3412
41. Lien Y. C., Feinstein S. I., Dodia C., Fisher A. B., The roles of peroxidase and phospholipase A2 activities of peroxiredoxin 6 in protecting pulmonary microvascular endothelial cells against peroxidative stress. Antioxidants & Redox Signaling 2012 16 440 451
42. Cox A. G., Brown K. K., Arner E. S. J., Hampton M. B., The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochemical Pharmacology 2008 76 9 1097 1109 2-s2.0-53649092133 10.1016/j.bcp.2008.08.021
43. Rowe D. D., Leonardo C. C., Recio J. A., Collier L. A., Willing A. E., Pennypacker K. R., Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction. The Journal of Biological Chemistry 2012 287 4177 4187
44. Cohn J. N., Ferrari R., Sharpe N., Cardiac remodeling-concepts and clinical implications: a consensus paper from an International Forum on Cardiac Remodeling. Journal of the American College of Cardiology 2000 35 3 569 582 2-s2.0-0034162004 10.1016/S0735-1097(99)00630-0 (Pubitemid 30167013)
45. Guttenplan N., Lee C., Frishman W. H., Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention: focus on caspase inhibition. Heart Disease 2001 3 5 313 318 2-s2.0-0035209423 (Pubitemid 33136300)